Article
Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults.
Atherosclerosis - 1 Aug 2014
Zuliani Giovanni, Morieri Mario Luca, Volpato Stefano, Maggio Marcello, Cherubini Antonio, Francesconi Daniela, Bandinelli Stefania, Paolisso Giuseppe, Guralnik Jack M, Ferrucci Luigi
Abstract excerpt
BACKGROUND: Although metabolic syndrome (MS) is a typical condition of middle-aged/older person, the association between MS and mortality risk has not been confirmed in people over 65 years. We hypothesized that while in the elderly MS phenotype might lose its value in predicting mortality risk, the two core factors of MS, i.e. insulin resistance (IR) and low grade systemic inflammation (LGSI) would not. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.